Attached files
file | filename |
---|---|
EX-32.2 - EX-32.2 - TETRAPHASE PHARMACEUTICALS INC | d847135dex322.htm |
EX-31.2 - EX-31.2 - TETRAPHASE PHARMACEUTICALS INC | d847135dex312.htm |
EX-31.1 - EX-31.1 - TETRAPHASE PHARMACEUTICALS INC | d847135dex311.htm |
EX-21.1 - EX-21.1 - TETRAPHASE PHARMACEUTICALS INC | d847135dex211.htm |
EX-32.1 - EX-32.1 - TETRAPHASE PHARMACEUTICALS INC | d847135dex321.htm |
EX-10.27 - EX-10.27 - TETRAPHASE PHARMACEUTICALS INC | d847135dex1027.htm |
EX-10.26 - EX-10.26 - TETRAPHASE PHARMACEUTICALS INC | d847135dex1026.htm |
EXCEL - IDEA: XBRL DOCUMENT - TETRAPHASE PHARMACEUTICALS INC | Financial_Report.xls |
10-K - FORM 10-K - TETRAPHASE PHARMACEUTICALS INC | d847135d10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-3 No. 333-195631) of Tetraphase Pharmaceuticals, Inc. |
(2) | Registration Statement (Form S-8 No. 333-198098) pertaining to Tetraphase Pharmaceuticals, Inc. 2014 Employee Stock Purchase Plan |
(3) | Registration Statement (Form S-8 No. 333-194125) pertaining to the 2013 Stock Incentive Plan of Tetraphase Pharmaceuticals, Inc., and |
(4) | Registration Statement (Form S-8 No. 333-189361) pertaining to the 2006 Stock Incentive Plan and the 2013 Stock Incentive Plan of Tetraphase Pharmaceuticals, Inc., |
of our report dated March 6, 2015, with respect to the consolidated financial statements of Tetraphase Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of Tetraphase Pharmaceuticals, Inc. for the year ended December 31, 2014.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 6, 2015